MedPath

Acetazolamide

acetaZOLAMIDE Tablets, USP Rx only

Approved
Approval ID

c19166fa-2cef-4c96-a956-ea540a8ba9c3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 8, 2023

Manufacturers
FDA

Eywa Pharma Inc

DUNS: 080465609

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acetazolamide

PRODUCT DETAILS

NDC Product Code71930-009
Application NumberANDA211556
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 14, 2023
Generic NameAcetazolamide

INGREDIENTS (6)

ACETAZOLAMIDEActive
Quantity: 250 mg in 1 1
Code: O3FX965V0I
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT

Acetazolamide

PRODUCT DETAILS

NDC Product Code71930-008
Application NumberANDA211556
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 14, 2023
Generic NameAcetazolamide

INGREDIENTS (6)

ACETAZOLAMIDEActive
Quantity: 125 mg in 1 1
Code: O3FX965V0I
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acetazolamide - FDA Drug Approval Details